Register for our free email digests:
Boston Children’s Hospital
Latest From XTuit Pharmaceuticals Inc.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
The privately-held biopharma, focused on fibrotic diseases and cancer, appointed oncology veteran Deborah Dunsire as president and CEO as the firm’s first drug candidates mature toward the clinic.
The demands of building new biotechs can take their toll, yet Alan Crane wears his 52 years and over two decades of high-risk biotech start-up investing lightly. He's built an exceptional number of companies during his tenure at Polaris, many of which have proved to be among the industry’s more successful emerging ventures.
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.